The company has entered into an informal and non-binding agreement with the Carden Capital Group to leverage the Regulation A+ as part of its strategic alignment to fund the 16 Million Dollars of development efforts of Paranotek and other strategic investment ventures related to those partnerships. Previous agreements with other prospective funding partners were permitted to amicably
expire.